Introduction
Regulatory T (Treg) cells constitute a unique subset of CD4 + T cells that control autoimmunity and inflammatory pathology to maintain immune homeostasis via actively suppressing selfreactive T cells (1, 2) . Foxp3, an X chromosome-encoded forkhead domain-containing transcription factor, is the master regulator responsible for the differentiation, maintenance, and function of Treg cells (3, 4) . Its mutation or deficiency is associated with excessive autoimmune diseases, as revealed in Scurfy mutant mice and human patients with immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndromes (5, 6) . Treg cells are generated in the thymus and migrate into the periphery to become naturally occurring Treg (nTreg) cells (7) . In addition, peripheral naive CD4 + T cells can also be induced into Foxp3 + Treg (iTreg) cells either by transforming growth factor β (TGF-β) in vitro (8) , or by high-dose antigen administration in vivo (9) . Unlike nTreg cells that possess stable genetic markers, iTreg cells may be only partially epigenetically modified (10) . Treg cells exert immunosuppressive activity via multiple mechanisms including cell-cell contacts or secretion of soluble factors such as IL-10 and TGF-β, or by influencing the stimulating APCs (11, 12) .
A growing body of evidence has indicated that Treg cells are able to suppress different types of T helper (Th) cell-mediated immune responses through the acquisition of specific T effector transcriptional programs and that there is functional specialization depending on the type of immune response (13) . For example, Treg lineage-specific suppression of Th1, Th2, and Th17 cells was demonstrated through specific transcription factors expressed in Treg cells including Tbx21 (T-bet), IRF4, and STAT3, respectively (14) (15) (16) . Additional studies have demonstrated that Treg cells display plasticity and can be converted into various effector Th cells in response to lymphopenia or inflammatory cytokine signals (17) (18) (19) (20) . However, the issue of Treg cell plasticity was largely disputed by a thorough investigation using different model systems (21) . A more recent work by Miyao et al. (22) attempted to provide an explanation for the conflicting observations by demonstrating that a minor population of uncommitted Foxp3 + T cells undergoes phenotypic changes to acquire inflammatory effector functions under certain conditions. However, the molecular regulatory mechanisms underlying Treg plasticity or maintenance and their importance in immune responses remain to be elucidated.
The posttranslational modification mediated by ubiquitin conjugation is one of the key regulatory mechanisms that control innate or adaptive immune responses (23, 24) . Ubiquitin conjugation to a protein substrate involves a cascade of enzymatic reactions including IL-4, E2, and E3 enzymes (25) . Itch is a HECT-type E3 ubiquitin ligase involved in the regulation of immune responses, as Itchdeficient mice develop a skin-scratching phenotype and immunological disorders manifested by lymphadenopathy, splenomegaly, and inflammation in the lungs and digestive tract (26) . The inflammatory phenotype is associated with hyperactivation of Itch-deficient CD4 + T cells that produce Th2 cytokines (27) . Our previous study using systemic Itch knockout mice suggested that Itch is involved in the generation of iTreg cells by targeting ubiquitination of the transcription factor TIEG1 (TGF-β-inducible early gene 1 product) (28) . However, another study demonstrated that overproduction of IL-4 renders Itch -/-T cells defective in differentiating into iTreg cells (29) . Given the dominant role of committed nTreg cells in immune tolerance induction, these previous studies raise the critical question of whether Itch plays an intrinsic role in controlling the development and function of nTreg cells. To address this issue, we generated Itch-floxed mice carrying the Treg cell-specific Foxp3-YFP-Cre gene to conditionally delete Itch in Treg cells. The mutant mice spontaneously developed skin disorder and massive multiorgan inflammation, accompanied by the hyperproduction of Th2-dependent Igs. Unlike the previous in vitro studies (28, 29) , Treg cell-restricted Itch deficiency did not affect homeostasis of, or Foxp3 expression in, these cells. Furthermore, Itch-deficient Treg cells exhibited intact suppressive activity both in vitro and in vivo. Interestingly, Itch deficiency in Treg cells resulted in the acquisition of the ability to produce Th2 inflammatory cytokines, which were further augmented in Itch -/-Foxp3-negative "ex-Treg" cells. The present study indicates that Treg cell-restricted Itch expression plays an intrinsic role in inhibiting the conversion of Treg cells into pathogenic Th2 effector cells, which is independent of Foxp3 induction, Treg cell suppressive function, and stability. Figure 1G ). The degree of lung and skin inflammation was scored on H&E-stained sections, as described in Methods ( Figure 1H) . A large number of leukocytes were present in the splenic red pulp of the mice ( Figure 1G ), however, the kidney and colon did not exhibit noticeable lesions in Itch fl/fl Foxp3 Cre mice (Supplemental Figure 2) . As Itch has been implicated in Th2-mediated immune diseases, we used an antigen-induced airway inflammation model of asthma. Young (4-to 5-week-old) Itch +/+ Foxp3 Cre or Itch fl/fl Foxp3 Cre mice were primed with OVA antigen in alum and subsequently challenged with aerosolized OVA. Twenty-four hours after the last OVA challenge, the mice were killed to measure several parameters that are indicative of airway inflammation. Itch fl/fl Foxp3 Cre mice exhibited more severe lung inflammation as evidenced by the increased infiltration of inflammatory cells in the BAL fluid ( Figure 1I ) and by histological analysis of lung tissue (Supplemental Figure 3A) . Consistent with these findings, we observed a dramatic increase in OVA-specific IgE and Th2 cytokines, including IL-4, IL-5, and IL-13, in the BAL fluid ( Figure 1J and Supplemental Figure 3B ). To determine whether the inflammatory disease observed in Itch fl/fl Foxp3 Cre mice is associated with augmented Th17 responses, we compared the susceptibility of Itch +/+ Foxp3 Cre or Itch fl/fl Foxp3 Cre mice to experimental autoimmune encephalomyelitis (EAE) induction. The onset, severity, and duration of EAE were indistinguishable in these two groups of mice (Supplemental Figure 4A ). We also found by histological analysis that there were no differences in infiltration of mononuclear cells into the spinal cord between Itch +/+ Foxp3 Cre and Itch fl/fl Foxp3 Cre mice (Supplemental Figure 4B) Figure 5A) . The Error bars indicate the mean (± SD). *P < 0.05; **P < 0.01; ***P < 0.001 (unpaired 2-tailed Student's t test).
Results

Ablation of Itch in
used an adoptive transfer model of colitis induced by transferring naive CD4 + cells into recombination-activating gene 1-deficient (Rag1 -/-) mice. The transfer of wild-type naive (CD45.1 + CD25 -CD45RB hi ) CD4 + T cells alone elicited colitis in Rag1 -/-recipient mice, manifested by gradual weight loss ( Figure 4B ), splenomegaly, and lymphadenopathy ( Figure 4C) . However, the cotransfer of either CD45.2 + wild-type or Itch-deficient Treg cells, together with the naive CD45RB hi CD4 + T cells, effectively suppressed the autoimmune phenotype of naive CD4 + T cells. Recipient mice given either wild-type or Itch-deficient Treg cells remained healthy without losing body weight. Histological analysis of recipients of wild-type or Itch-deficient Treg cells also showed a low degree of inflammation compared with that of mice that did not receive Treg cells (Figure 4D ), suggesting that Itch-deficient Treg cells . Total amounts of each Ig subclass were determined by ELISA using isotype-specific antibodies. *P < 0.05; **P < 0.01; ***P < 0.001 (unpaired 2-tailed Student's t test).
have competent immune-suppressive activity in vivo. In addition, we analyzed the percentage and total number of the CD45.1 + progeny of CD4 + CD45RB hi T cells and the CD45.2 + progeny of Treg cells in the Rag1 -/-recipients. In the presence of either wild-type or Itch-deficient Treg cells, naive T cell expansion was significantly reduced ( Figure 4E ). The ratios of CD45.1 + cells/CD45.2 + cells in the recipient mice given Itch-deficient Treg cells were moderately decreased compared with those in the mice that received wildtype Treg cells in all organs analyzed (Supplemental Figure 9A ). This phenomenon was likely due to the enhanced expansion of Itch-deficient Treg cells in the Rag1 -/-hosts, since the total number of Itch-deficient Treg cells was increased compared with that of wild-type Treg cells ( Figure 4E ). We next examined whether the increased expansion of Itch-deficient Treg cells in lymphopenic hosts was associated with their Foxp3 instability. The wild-type and Itch-deficient Treg cells obtained from the Rag1 -/-hosts displayed similar amounts of Foxp3 ( Figure 4F ), suggesting that Itch was dispensable for maintaining Foxp3 stability.
To further reinforce this conclusion, we examined the stability of Treg cells using a genetic fate-mapping approach: Itch fl/fl Foxp3 Cre mice were crossed with Rosa26 red fluorescent protein (RFP) Cre reporter mice (R26R), in which RFP is expressed only after Cremediated excision of a loxP-flanked stop codon (31) . The loss of YFP expression in the RFP + CD4 + T cells marks the generation of latent or ex-Treg cells, which was reported in autoimmune mice (18) . By using this fate-mapping approach, we examined whether Itch deficiency accelerates the generation of YFP -RFP + ex-Treg cells under inflammatory conditions. We observed that Figure 5A and Supplemental Figure 11 ). The production of IL-4 by Itch-deficient Treg cells was confirmed by intracellular cytokine staining and RT-PCR analysis (Supplemental Figure 12, A and B) . As expected, control wild-type Treg cells did not produce noticeable amounts of proinflammatory cytokines. Furthermore, we found that the increase in Th2 cytokine production was excessively augmented in Itch -/-Foxp3-negative ex-Treg cells, as measured by Bio-Plex cytokine array analysis ( Figure 5B ) and flow cytometry (Supplemental Figure 12C ). Flow cytometric analysis showed that Itch-deficient Treg cells have an activated phenotype with reduced CD62L and increased CD44 expression ( Figure 5C ). Compared with wild-type Treg cells, Itch-deficient Treg cells expressed high levels of GITR (TNFRSF18) and ICOS ( Figure 5D ). The levels of CD25 (IL2RA) and CTLA4 were not altered in Itch-deficient Treg cells ( Figure  5D ), consistent with a potent immunosuppressive activity of Figure 7A ). Increased GATA3 expression in Itch-deficient Treg cells was also seen by flow cytometry ( Figure 7B ). In addition, immunoblot analysis showed that GATA3 expression was markedly increased in TCR-stimulated Itch-deficient Treg cells compared with wild-type Treg cells ( Figure   7C ). TCR stimulation also induced Tyr-641 phosphorylation of the signal transducer and activator of transcription 6 (STAT6) in Itch-deficient Treg cells (Figure 7 , B and C). To investigate whether the inhibition of Th2 transcription factors is able to rescue the Th2 phenotype in Itch-deficient Treg cells, we generated retroviral vectors expressing both mAmetrine and an shRNA targeting Gata3 or Stat6. Knockdown efficiency was confirmed by RT-PCR (data not shown). Bone marrow cells isolated from Itch fl/fl Foxp3 Cre mice were transduced with the retrovirus carrying each of the shRNAs or the control shRNA and were then transplanted into lethally irradiated C57BL/6 mice. Eight weeks later, newly reconstituted mAmetrine + YFP + CD4 + Treg cells were sorted from the spleens and lymph nodes of bone marrow chimeric mice and then stimulated with anti-CD3/CD28 antibodies in vitro. The elevated production of Th2 cytokines in Itch-deficient Treg cells was completely inhibited by Gata3 or Stat6 knockdown, as measured by an ELISA assay ( Figure 7D ), indicating that unrestrained STAT6 activation and GATA3 expression in Itch-deficient Treg cells are associated with dysregulated Th2 responses.
Itch-deficient Treg cells instruct Th2 cell differentiation in vitro.
Since Treg cells constitute a small population, we reasoned that Th2 cytokine production by Itch-deficient Treg cells does not fully account for the pathogenic Th2 responses observed in Itch fl/fl Foxp3 Cre mice. We thus hypothesized that the cytokines secreted from Treg cells instruct naive T cells to develop into Th2 cells, thereby promoting the development of pathogenic Th2 responses and associated disease. To test this, we stimulated naive CD4 + T cells in the presence of culture supernatants from Itch-deficient Treg cells and found that they instructed naive T cells to differentiate into IL -4-producing effector cells ( Figure 8A ). The mRNA levels of Il4 and Il5, but not Ifng, were also increased in these cells ( Figure 8B ). In addition, RT-PCR analysis showed the upregulation of Gata3 concomitant with the sup- 
Discussion
Previous studies including our own have demonstrated that Itch deficiency results in the reduction of Foxp3 expression and decreased induction and differentiation of iTreg cells (28, 29) . It was striking to see that Foxp3-restricted deletion of Itch did not affect Foxp3 expression or the development and differentiation of nTreg cells. One explanation is that the differentiation of iTreg cells requires the stimulation of TGF-β signaling (8), which may not be necessary for nTreg cells (32) . The increased IL-4 production accounted for the resistance of naive CD4 + cell conversion into iTreg cells (29) , which is consistent with the observation that IL-4-driven GATA3 expression counteracts Foxp3 expression in iTreg cells (33, 34) . However, recent genetic studies clearly showed that GATA3 expression is required for nTreg development and function (20, 35) . It would be reasonable to reconcile the different roles of Itch in iTreg and nTreg cells by the fact that the iTreg studies used CD4 + T cells from Itchy mutant mice, which are chronically activated and are therefore resistant to Foxp3 induction.
Thus, the present study potentially highlights the importance of studying the intrinsic molecular regulation of Foxp3 using committed nTreg cells instead of iTreg cells from inflamed mice, which may not reveal the true biological relevance of Foxp3 regulation.
Foxp3-restricted deletion of Itch leads to multiorgan inflammation and skin disorders. However, Itch deficiency in committed Treg cells did not alter in vitro suppressive activity as measured by coculture assay or the inhibitory capability of CD4 + T cell autoreactivity in the mouse adoptive transfer model of colitis. Many mechanisms have been proposed for the suppressive activity of Treg cells, including CTLA-4-mediated suppression of APCs, the competition for IL-2 consumption by the high-affinity IL-2 receptor α chain CD25, and the expression of IL-10 (reviewed in ref. 13 ). We indeed observed that the expression of various surface markers was not changed in Itch -/-YFP + Treg cells. In addition, the expression of IL-10, which has been shown to be critical for the maintenance of mucosal homeostasis and Treg function (30) Cytokine concentration in the culture supernatants was measured by an ELISA assay. Data are compiled from two independent experiments with four mice per group. Error bars indicate the mean (± SD). *P < 0.05; **P < 0.01; ***P < 0.001. (38) . However, other possible mechanisms, such as para-activated CD4 + T cells or other inflammatory cells, require further investigation. Itch -/-Treg cells showed increased expression of GATA3 and upregulated phosphorylation of STAT6, both of which have been implicated in IL-4 production (39, 40) , even though an intrinsic role of STAT6 in Treg cells is questionable (35, 41) . The effects of GATA3 and STAT6 on IL-4 production were reversed by in vivo shRNA-based knockdown in Itch -/-Treg cells from bone marrow chimeric mice. An immediate question is whether phosphorylated STAT6 acts on the expression of the Gata3 gene or vice versa. It should be noted that previous studies documented that Itch targets JunB for ubiquitination and regulates JunB-mediated Il4 gene transcription (27, 29, 42) . However, JunB is not expressed in resting Treg cells, and their stimulation does not lead to a further increase in JunB accumulation in Itch -/-Treg cells (data not shown). Thus, the present study raises a new question regarding the exact mechanism underlying Itch regulation of Th2 cytokines in Treg cells. At present, we consider it factor Tbx21 is required for homeostasis and Treg cell function during a Th1 response (14) , whereas the expression of STAT3 in Treg cells is required for the prevention of Th17 responses (15, 16) . Of relevance to the current study, Treg cell-specific deletion of IRF4 results in excessive Th2 responses by the increased production of IL-4 and IL-5 cytokines (15). However, unlike Irf4 -/-Treg cells, which displayed reduced IL-10 production and attenuated in vitro suppressive activity, Itch deficiency does not affect these events. It should be noted that Itch deficiency does not change Treg cell homeostasis or cell death. A recent study documented that Bcl-6 is required for the control of Th2 responses (36) , since Bcl-6 -/-Treg cells from conventional knockout mice displayed a phenotype similar to that in our current study. However, Itch deficiency does not affect Bcl-6 expression in an in vitro culture system (data not shown). The use of Treg cells from total Bcl-6-knockout mice, which display profound Th2 responses, may also complicate the interpretation. Thus, the present study suggests a unique pathway of molecular regulation by Itch that controls Th2 responses independent of Foxp3 function.
The current study also addresses the controversial issue of Treg cell stability and maintenance under normal or inflammatory conditions. Previous studies have documented that Treg cells can lose their Foxp3 expression and be converted into pathogenic ex-Treg cells (18, 37) . However, a study using acute and induced labeling of Foxp3 + Treg cells argued that they are very stable under various perturbed conditions (21) . By using a newly generated fate-mapping strategy, Hori's group provided an alternative explanation in that the committed nTreg cells are stable, whereas a minor population of Treg cells displays transient or promiscuous Foxp3 expression and unstable properties (22) . In our fate-mapping study using the double-reporter mice, we found that Itch deficiency does not affect the generation of the RFP + YFP -ex-Treg population, even in the 4-month-old mice with severe inflammation. In addition, in vitro culture of the RFP + YFP + Treg cells results in the genera- 
